PatentsUSA
Supreme Court Rules Against Patenting of BRCA1 and BRCA2 Genes in Landmark ACLU Case
In a pivotal decision on June 13, 2013, the U.S. Supreme Court struck down patents on the BRCA1 and BRCA2 genes, which are linked to hereditary breast and ovarian cancer. The ruling followed a lawsuit initiated by the American Civil Liberties Union (ACLU) and the Public Patent Foundation (PUBPAT) on behalf of a broad…
Friday, October 9, 2009